港股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

九源基因

10.100

+0.4004.12%

成交量：87.44萬

成交額：866.71萬

市值：24.75億

市盈率：13.62

高：10.100

開：9.700

低：9.480

收：9.700

資料載入中...

總覽公司新聞公告

九源基因發佈上市後首份業績公告！2024年實現營收13.69億元骨科產品複合增長率超33%

智通财经网

首款國產司美格魯肽要來了？九源基因在財報中預計下半年獲批

九源基因(02566)發佈年度業績股東應占溢利1.39億元同比增加15.72% 擬派發末期股息每10股0.56元

未來兩個月“基石投資者”解禁名單出爐！九源基因已浮虧1.19億！

九源基因03月20日主力淨流出17萬元散戶資金買入

九源基因03月14日主力淨流入82萬元散户資金拋售

九源基因03月06日主力淨流入51萬元散户資金拋售

九源基因02月26日遭主力拋售18萬元

九源基因02月20日獲主力加倉27萬元

九源基因擬更名為“杭州九源基因生物醫藥股份有限公司”

九源基因(02566.HK)建議更改公司名稱

阿斯达克财经

九源基因(02566)擬更名為“杭州九源基因生物醫藥股份有限公司”

九源基因(02566)股價上升6.724%，現價港幣$6.19

阿斯达克财经

九源基因（02566.HK）1月24日收盤上漲3.1%，成交52.14萬港元

九源基因1月22日收盤下跌1.44%，成交57.05萬港元

九源基因：聚乙二醇化藥物獲批上市

九源基因(02566.HK)吉新芬獲國家藥監局批准上市

阿斯达克财经

九源基因(02566)：吉新芬®獲國家藥品監督管理局批准上市

九源基因(02566)股價上升5.254%，現價港幣$5.81

阿斯达克财经

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/02566/news?page=3"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02566","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02566\",,,,,undefined,":{"symbol":"02566","market":"HK","secType":"STK","nameCN":"九源基因","latestPrice":10.1,"timestamp":1752826115016,"preClose":9.7,"halted":0,"volume":874400,"delay":0,"floatShares":109000000,"shares":245000000,"eps":0.741592738183987,"marketStatus":"休市中","change":0.4,"latestTime":"07-18 16:08:35","open":9.7,"high":10.1,"low":9.48,"amount":8667136,"amplitude":0.063918,"askPrice":10.1,"askSize":9400,"bidPrice":10.08,"bidSize":30200,"shortable":0,"etf":0,"ttmEps":0.741592738183987,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1753061400000},"marketStatusCode":7,"adr":0,"listingDate":1732723200000,"exchange":"SEHK","adjPreClose":9.7,"dividendRate":0.006011,"openAndCloseTimeList":[[1752802200000,1752811200000],[1752814800000,1752825600000]],"volumeRatio":1.048441247115539,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02566\",,,,,undefined,":{"symbol":"02566","floatShares":109000000,"roa":"6.08%","roe":"11.47%","lyrEps":0.741593,"volumeRatio":1.048441247115539,"shares":245000000,"dividePrice":0.061193,"high":10.1,"amplitude":0.063918,"preClose":9.7,"low":9.48,"week52Low":5.151,"pbRate":"1.49","psRate":"1.65","week52High":11.84,"institutionHeld":0,"latestPrice":10.1,"committee":0.525253,"eps":0.741592738183987,"divideRate":0.006059,"volume":874400,"delay":0,"ttmEps":0.741592738183987,"open":9.7,"prevYearClose":6.563,"prevWeekClose":9.61,"prevMonthClose":7.85,"prevQuarterClose":7.85,"fiveDayClose":9.61,"twentyDayClose":8.32,"sixtyDayClose":5.887},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02566\",pageSize:20,pageCount:3,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2522813366","title":"九源基因發佈上市後首份業績公告！2024年實現營收13.69億元 骨科產品複合增長率超33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2522813366","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522813366?lang=zh_tw&edition=fundamental","pubTime":"2025-03-27 08:25","pubTimestamp":1743035138,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，3月26日，九源基因公布了上市后首份年度业绩公告，公司2024年实现总收入13.69亿元，同比增长6.4%;净利润1.386亿元，同比增长15.7%。核心产品营收稳健增长 持续耕耘研发创新加速产品线拓展财报显示，2024年，九源基因继续深耕骨科、代谢、肿瘤及血液四大治疗领域，实现全面突破，全年营业收入达13.69亿元，同比增长6.4%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025032708320694c21c7d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025032708320694c21c7d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02566"],"gpt_icon":0},{"id":"2522848943","title":"首款國產司美格魯肽要來了？九源基因在財報中預計下半年獲批","url":"https://stock-news.laohu8.com/highlight/detail?id=2522848943","media":"第一财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522848943?lang=zh_tw&edition=fundamental","pubTime":"2025-03-26 21:51","pubTimestamp":1742997060,"startTime":"0","endTime":"0","summary":"2024年4月，九源基因在国内提交了司美格鲁肽治疗二型糖尿病的上市申请，在国内诸多款司美格鲁肽生物类似药中拔得了头筹。诺和诺德的司美格鲁肽专利面临到期，如在中国市场，专利到期日是在2026年3月20日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2025-03-26/doc-ineqyzvi8756172.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2025-03-26/doc-ineqyzvi8756172.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02566"],"gpt_icon":0},{"id":"2522437803","title":"九源基因(02566)發佈年度業績 股東應占溢利1.39億元 同比增加15.72% 擬派發末期股息每10股0.56元","url":"https://stock-news.laohu8.com/highlight/detail?id=2522437803","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522437803?lang=zh_tw&edition=fundamental","pubTime":"2025-03-26 20:53","pubTimestamp":1742993616,"startTime":"0","endTime":"0","summary":"智通财经APP讯，九源基因 发布截至2024年12月31日止年度业绩，该集团期内取得收益13.69亿元，同比增加6.4%;公司拥有人应占溢利1.39亿元，同比增加15.72%;每股基本盈利0.68元;拟派发末期股息每10股0.56元。销售货品的收益由截至2023年12月31日止年度的12.19亿元增加6.6%至截至2024年12月31日止年度的12.99亿元，这与骨优导的销售收益的增长一致。集团的毛利由截至2023年12月31日止年度的9.91亿元增加9.2%至截至2024年12月31日止年度的10.82亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1268340.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02566"],"gpt_icon":0},{"id":"2520439966","title":"未來兩個月“基石投資者”解禁名單出爐！九源基因已浮虧1.19億！","url":"https://stock-news.laohu8.com/highlight/detail?id=2520439966","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520439966?lang=zh_tw&edition=fundamental","pubTime":"2025-03-20 17:52","pubTimestamp":1742464320,"startTime":"0","endTime":"0","summary":"　　据LiveReport大数据统计，四至五月份共计11家公司的基石解禁，其中四月份有4家，5月份有7家；距离解禁日最近的公司为卡罗特，13天后基石将解禁5418.30万股，占解禁后流通股股本的35.32%。　　据LiveReport大数据，截至3月20日11家公司的基石中有4家浮亏，分别为卡罗特、华昊中天医药-B、傲基股份及九源基因，分别浮亏金额约为433.46万、8231.32万、2932.86万及1.19亿港元，截至当前，基石浮亏最大的公司为九源基因。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2025-03-20/doc-ineqiarh4712746.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02566"],"gpt_icon":0},{"id":"2520438706","title":"九源基因03月20日主力淨流出17萬元 散戶資金買入","url":"https://stock-news.laohu8.com/highlight/detail?id=2520438706","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520438706?lang=zh_tw&edition=fundamental","pubTime":"2025-03-20 16:16","pubTimestamp":1742458596,"startTime":"0","endTime":"0","summary":"03月20日, 九源基因股价跌0.83%，报收7.16元，成交金额156万元，换手率0.20%，振幅1.39%，量比0.55。九源基因今日主力资金净流出17万元，上一交易日主力净流出0万元。该股近5个交易日上涨5.60%，主力资金累计净流入65万元；近20日主力资金累计净流入95万元，其中净流入天数为6日。该股主力净额占比0.02%，港股市场排名2378/2651。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250320165603a43b0dcc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250320165603a43b0dcc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02566"],"gpt_icon":0},{"id":"2519087399","title":"九源基因03月14日主力淨流入82萬元 散户資金拋售","url":"https://stock-news.laohu8.com/highlight/detail?id=2519087399","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519087399?lang=zh_tw&edition=fundamental","pubTime":"2025-03-14 16:15","pubTimestamp":1741940150,"startTime":"0","endTime":"0","summary":"03月14日, 九源基因股价涨7.23%，报收7.27元，成交金额903万元，换手率1.13%，振幅9.59%，量比7.02。九源基因今日主力资金净流入82万元，上一交易日主力净流出102万元。该股近5个交易日上涨6.91%，主力资金累计净流入53万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入155万元，其中净流入天数为9日。该股主力净额占比0.10%，港股市场排名119/2653。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250314164939ab653dce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250314164939ab653dce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02566"],"gpt_icon":0},{"id":"2517136013","title":"九源基因03月06日主力淨流入51萬元 散户資金拋售","url":"https://stock-news.laohu8.com/highlight/detail?id=2517136013","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517136013?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 16:15","pubTimestamp":1741248959,"startTime":"0","endTime":"0","summary":"03月06日, 九源基因股价涨1.68%，报收6.64元，成交金额172万元，换手率0.24%，振幅3.83%，量比1.17。九源基因今日主力资金净流入51万元，上一交易日主力净流出0万元。该股近5个交易日下跌5.14%，主力资金累计净流入31万元；近20日主力资金累计净流入134万元，其中净流入天数为8日。该股主力净额占比0.07%，港股市场排名171/2651。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306165519a2622928&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306165519a2622928&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02566"],"gpt_icon":0},{"id":"2514886189","title":"九源基因02月26日遭主力拋售18萬元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514886189","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514886189?lang=zh_tw&edition=fundamental","pubTime":"2025-02-26 16:17","pubTimestamp":1740557839,"startTime":"0","endTime":"0","summary":"02月26日, 九源基因股价跌0.43%，报收6.98元，成交金额144万元，换手率0.19%，振幅2.71%，量比0.52。九源基因今日主力资金净流出18万元，上一交易日主力净流出4万元。该股近5个交易日下跌1.13%，主力资金累计净流入41万元；近20日主力资金累计净流入93万元，其中净流入天数为7日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226165106abdd9447&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226165106abdd9447&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02566"],"gpt_icon":0},{"id":"2512410418","title":"九源基因02月20日獲主力加倉27萬元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512410418","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512410418?lang=zh_tw&edition=fundamental","pubTime":"2025-02-20 16:15","pubTimestamp":1740039311,"startTime":"0","endTime":"0","summary":"02月20日, 九源基因股价涨0.14%，报收7.07元，成交金额196万元，换手率0.26%，振幅3.12%，量比0.47。九源基因今日主力资金净流入27万元，上一交易日主力净流入2万元。该股近5个交易日上涨14.96%，主力资金累计净流入43万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流出39万元，其中净流出天数为3日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220161527abd5ddd9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220161527abd5ddd9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02566"],"gpt_icon":0},{"id":"2511537098","title":"九源基因擬更名為“杭州九源基因生物醫藥股份有限公司”","url":"https://stock-news.laohu8.com/highlight/detail?id=2511537098","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511537098?lang=zh_tw&edition=fundamental","pubTime":"2025-02-13 08:06","pubTimestamp":1739405160,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n　　九源基因（02566）公布，董事会已议决建议将公司的中文名称由“杭州九源基因工程股份有限公司”更改为“杭州九源基因生物医药股份有限公司”，及将公司的英文名称由“Hangzhou Jiuyuan Gene Engineering Co．，Ltd．”更改为“Hangzhou Jiuyuan Genetic Biopharmaceutical Co．，Ltd．”\n\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2025-02-13/doc-inekhuek1010530.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02566","161726","399441"],"gpt_icon":0},{"id":"2511355853","title":"九源基因(02566.HK)建議更改公司名稱","url":"https://stock-news.laohu8.com/highlight/detail?id=2511355853","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511355853?lang=zh_tw&edition=fundamental","pubTime":"2025-02-13 08:06","pubTimestamp":1739405160,"startTime":"0","endTime":"0","summary":"九源基因(02566.HK) 公布，其已议决建议将公司的中文名称由“杭州九源基因工程股份有限公司”更改为“杭州九源基因生物医药股份有限公司”，以及将公司的英文名称由“Hangzhou Jiuyuan Gene Engineering Co., Ltd.”更改为“Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd.”。九源基因解释，建议更改公司名称旨在全面地反映公司的行业定位，以及准确地反映公司的未来战略发展方向。(js/w)(港股报价延迟最少十五分钟。)AASTOCKS新闻","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20241126155522559_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20241126155522559_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1416870/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02566"],"gpt_icon":0},{"id":"2510308228","title":"九源基因(02566)擬更名為“杭州九源基因生物醫藥股份有限公司”","url":"https://stock-news.laohu8.com/highlight/detail?id=2510308228","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510308228?lang=zh_tw&edition=fundamental","pubTime":"2025-02-12 22:46","pubTimestamp":1739371616,"startTime":"0","endTime":"0","summary":"智通财经APP讯，九源基因(02566)公布，董事会已议决建议将公司的中文名称由“杭州九源基因工程股份有限公司”更改为“杭州九源基因生物医药股份有限公司”，及将公司的英文名称由“Hangzhou Jiuyuan Gene Engineering Co.,Ltd.”更改为“Hangzhou Jiuyuan Genetic Biopharmaceutical Co.,Ltd.”","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1249111.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02566","161726","399441"],"gpt_icon":0},{"id":"2509678897","title":"九源基因(02566)股價上升6.724%，現價港幣$6.19","url":"https://stock-news.laohu8.com/highlight/detail?id=2509678897","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509678897?lang=zh_tw&edition=fundamental","pubTime":"2025-02-07 14:48","pubTimestamp":1738910880,"startTime":"0","endTime":"0","summary":"[上升股]九源基因(02566) 股价在下午02:48比前收市价上升6.724%，现股价为港币$6.19。至目前为止，今日最高价为$6.19，而最低价为$5.7。总成交量为21万股，总成交金额为港币$122.886万。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180416150419953_s.png","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180416150419953_s.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2502074530/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02566"],"gpt_icon":0},{"id":"2505807128","title":"九源基因（02566.HK）1月24日收盤上漲3.1%，成交52.14萬港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505807128","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505807128?lang=zh_tw&edition=fundamental","pubTime":"2025-01-24 16:26","pubTimestamp":1737707198,"startTime":"0","endTime":"0","summary":"1月24日，截至港股收盘，恒生指数上涨1.86%，报20066.19点。九源基因收报5.65港元/股，上涨3.1%，成交量9.3万股，成交额52.14万港元，振幅4.2%。最近一个月来，九源基因累计跌幅19.77%，今年来累计跌幅16.97%，跑输恒生指数-1.79%的跌幅。财务数据显示，截至2024年6月30日，九源基因实现营业总收入7.02亿元，同比增长5.87%；归母净利润1.05亿元，同比增长9.33%；毛利率76.96%，资产负债率29.96%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/01/24162647787599.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["02566"],"gpt_icon":0},{"id":"2505713634","title":"九源基因1月22日收盤下跌1.44%，成交57.05萬港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505713634","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505713634?lang=zh_tw&edition=fundamental","pubTime":"2025-01-22 16:59","pubTimestamp":1737536379,"startTime":"0","endTime":"0","summary":"1月22日，截至港股收盘，恒生指数下跌1.63%，报19778.77点。九源基因收报5.49港元/股，下跌1.44%，成交量10.26万股，成交额57.05万港元，振幅3.05%。最近一个月来，九源基因累计跌幅19.5%，今年来累计跌幅16.82%，跑输恒生指数-1.4%的跌幅。财务数据显示，截至2024年6月30日，九源基因实现营业总收入7.02亿元，同比增长5.87%；归母净利润1.05亿元，同比增长9.33%；毛利率76.96%，资产负债率29.96%。机构评级方面，目前暂无机构对该股做出投资评级建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122170407986f2781&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122170407986f2781&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02566"],"gpt_icon":0},{"id":"2505959132","title":"九源基因：聚乙二醇化藥物獲批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2505959132","media":"和讯网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505959132?lang=zh_tw&edition=fundamental","pubTime":"2025-01-21 09:33","pubTimestamp":1737423225,"startTime":"0","endTime":"0","summary":"【九源基因：聚乙二醇化人粒细胞刺激因子注射液获批上市】九源基因公布，其聚乙二醇化人粒细胞刺激因子注射液已获国家药品监督管理局批准上市。该注射液用于治疗成年非髓性恶性肿瘤患者，可降低相关感染发生率。其由人粒细胞刺激因子与 20KD 聚乙二醇交联并经纯化获得，具有诸多优点。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121103708986d7c8e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121103708986d7c8e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02566"],"gpt_icon":0},{"id":"2505233999","title":"九源基因(02566.HK)吉新芬獲國家藥監局批准上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2505233999","media":"阿斯达克财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505233999?lang=zh_tw&edition=fundamental","pubTime":"2025-01-21 01:12","pubTimestamp":1737393120,"startTime":"0","endTime":"0","summary":"九源基因(02566.HK) 公布，聚乙二醇化人粒细胞刺激因子注射液(商标名︰吉新芬)已获中国国家药监局批准上市，用于治疗成年非髓性恶性肿瘤患者在接受易引起发热性中性粒细胞减少症的骨髓抑制性抗癌药物治疗时，降低以发热性中性粒细胞减 少症为表现的感染发生率。(de/d)(港股报价延迟最少十五分钟。)AASTOCKS新闻","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20241126155526856_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20241126155526856_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1411882/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02566"],"gpt_icon":0},{"id":"2504240227","title":"九源基因(02566)：吉新芬®獲國家藥品監督管理局批准上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2504240227","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2504240227?lang=zh_tw&edition=fundamental","pubTime":"2025-01-20 20:56","pubTimestamp":1737377798,"startTime":"0","endTime":"0","summary":"智通财经APP讯，九源基因(02566)公布，聚乙二醇化人粒细胞刺激因子注射液(商标名：吉新芬®)已获中华人民共和国国家药品监督管理局批准上市，用于治疗成年非髓性恶性肿瘤患者在接受易引起发热性中性粒细胞减少症的骨髓抑制性抗癌药物治疗时，降低以发热性中性粒细胞减少症为表现的感染发生率。吉新芬®由人粒细胞刺激因子(hG-CSF)与20KD聚乙二醇交联并经纯化获得，半衰期明显延长，生物稳定性增强，不易被酶解，免疫原性与抗原性降低，不易产生中和性抗体。聚乙二醇化人粒细胞刺激因子(PEG-hG-CSF)一个化疗周期仅需一次给药，提高患者依从性，有效保障患者安全及化疗方案足剂量足疗程实施。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1240704.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02566"],"gpt_icon":0},{"id":"2504644540","title":"九源基因(02566)股價上升5.254%，現價港幣$5.81","url":"https://stock-news.laohu8.com/highlight/detail?id=2504644540","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2504644540?lang=zh_tw&edition=fundamental","pubTime":"2025-01-20 10:30","pubTimestamp":1737340200,"startTime":"0","endTime":"0","summary":"[上升股]九源基因(02566) 股价在上午10:30比前收市价上升5.254%，现股价为港币$5.81。至目前为止，今日最高价为$5.81，而最低价为$5.54。总成交量为1.92万股，总成交金额为港币$10.875万。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180126133718217_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180126133718217_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2501203437/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02566"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":3,"totalSize":59,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02566\",params:#limit:5,,,undefined,":[{"date":"2025-06-13","symbol":"02566","amount":0.056,"announcedDate":"2025-03-26","type":"dividend","lastAmount":null,"market":"HK","newRecordDate":"2025-06-16","defaultRemindTime":1749778200000,"name":"九源基因","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-30","payableDate":"2025-06-16","currency":"CNY","dateTimestamp":1749744000000,"payDate":"2025-07-30"},{"date":"2025-03-26","symbol":"02566","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1742952600000,"name":null,"time":"","dateTimestamp":1742918400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02566\",market:\"HK\",,,undefined,":[{"executeDate":"2025-06-13","recordDate":"2025-06-16","paymentDate":"2025-07-30","value":0.056,"currency":"CNY"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02566\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02566\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02566","date":"2025-07-18","current":16.959198,"percent":0.993421,"low":9.307514,"twenty":10.204599,"median":11.508443,"eighty":13.325525,"high":18.134776,"avg":11.910971,"sd":1.944968,"marketCap":2478527880},"quantilePoints":[{"date":"2024-12-06","current":14.097915,"twenty":14.208262,"median":14.275695,"eighty":14.595644,"marketCap":1946012484},{"date":"2024-12-13","current":13.217326,"twenty":13.348436,"median":13.95821,"eighty":14.334483,"marketCap":1820859096},{"date":"2024-12-20","current":12.20261,"twenty":12.40882,"median":13.381214,"eighty":14.243818,"marketCap":1673619816},{"date":"2024-12-27","current":12.158366,"twenty":12.254449,"median":13.1954,"eighty":14.180675,"marketCap":1666257852},{"date":"2025-01-03","current":11.126814,"twenty":12.0799,"median":12.46117,"eighty":14.042033,"marketCap":1526380536},{"date":"2025-01-10","current":9.714633,"twenty":11.141125,"median":12.29741,"eighty":13.763077,"marketCap":1327607508},{"date":"2025-01-17","current":9.904165,"twenty":10.518129,"median":12.180488,"eighty":13.509332,"marketCap":1354601376},{"date":"2025-01-24","current":10.07429,"twenty":9.9409,"median":12.04207,"eighty":13.348436,"marketCap":1386503220},{"date":"2025-01-28","current":10.358786,"twenty":9.995541,"median":11.819979,"eighty":13.282881,"marketCap":1433128992},{"date":"2025-02-07","current":11.238302,"twenty":10.0243,"median":11.162591,"eighty":13.191014,"marketCap":1546012440},{"date":"2025-02-14","current":11.154484,"twenty":10.062805,"median":11.126814,"eighty":12.776093,"marketCap":1533742500},{"date":"2025-02-21","current":12.73316,"twenty":10.073062,"median":11.193598,"eighty":12.735779,"marketCap":1757055408},{"date":"2025-02-28","current":11.508443,"twenty":10.189099,"median":11.508443,"eighty":12.653552,"marketCap":1582822260},{"date":"2025-03-07","current":12.084413,"twenty":10.276651,"median":11.554796,"eighty":12.584056,"marketCap":1668711840},{"date":"2025-03-14","current":12.91496,"twenty":10.28916,"median":11.611229,"eighty":12.584056,"marketCap":1784049276},{"date":"2025-03-21","current":12.244709,"twenty":10.311241,"median":11.810026,"eighty":12.735779,"marketCap":1690797732},{"date":"2025-03-28","current":11.696332,"twenty":10.344738,"median":11.831112,"eighty":12.72799,"marketCap":1734969516},{"date":"2025-04-03","current":10.807781,"twenty":10.395616,"median":11.800074,"eighty":12.674918,"marketCap":1600000176},{"date":"2025-04-11","current":9.828764,"twenty":10.27298,"median":11.65378,"eighty":12.589531,"marketCap":1445398932},{"date":"2025-04-17","current":9.988361,"twenty":10.075173,"median":11.569961,"eighty":12.56072,"marketCap":1472392800},{"date":"2025-04-25","current":10.079541,"twenty":10.050182,"median":11.463659,"eighty":12.511173,"marketCap":1487116728},{"date":"2025-05-02","current":10.290636,"twenty":10.067013,"median":11.287756,"eighty":12.494061,"marketCap":1467484824},{"date":"2025-05-09","current":10.406872,"twenty":10.062805,"median":11.203375,"eighty":12.472285,"marketCap":1494478692},{"date":"2025-05-16","current":10.339488,"twenty":10.073062,"median":11.154484,"eighty":12.457737,"marketCap":1496932680},{"date":"2025-05-23","current":10.443848,"twenty":10.076938,"median":11.100884,"eighty":12.429027,"marketCap":1516564584},{"date":"2025-05-30","current":10.499086,"twenty":10.079206,"median":11.063697,"eighty":12.408842,"marketCap":1531288512},{"date":"2025-06-06","current":10.405237,"twenty":10.102813,"median":10.92653,"eighty":12.402573,"marketCap":1521472560},{"date":"2025-06-13","current":16.776007,"twenty":10.127345,"median":11.063697,"eighty":12.429027,"marketCap":2453988000},{"date":"2025-06-20","current":13.783342,"twenty":10.148232,"median":11.100884,"eighty":12.535947,"marketCap":2012270160},{"date":"2025-06-27","current":13.241991,"twenty":10.175286,"median":11.154484,"eighty":12.72799,"marketCap":1938650520},{"date":"2025-07-04","current":14.247042,"twenty":10.191457,"median":11.198369,"eighty":12.80722,"marketCap":2085889800},{"date":"2025-07-11","current":16.12378,"twenty":10.199228,"median":11.287756,"eighty":13.164345,"marketCap":2358282468},{"date":"2025-07-18","current":16.959198,"twenty":10.204599,"median":11.508443,"eighty":13.325525,"marketCap":2478527880}],"updateTime":1752902851476}}}